Showing results (471-480 of 510) with videos related to

Sort By:
Pageof 51
JACC. Clinical Electrophysiology|May 26, 2018
Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH TrialKathryn Coyle, Doug Coyle, Isabelle Nault, et al.
The Journal of Clinical Psychiatry|June 20, 2020
Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 ReportRudolf Uher, Benicio N Frey, Lena C Quilty, et al.
Ebiomedicine|October 2, 2015
Astroglial Control of the Antidepressant-Like Effects of Prefrontal Cortex Deep Brain StimulationA Etiévant, C Oosterhof, C Bétry, et al.
BMC Psychiatry|August 2, 2014
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersMartin A Katzman, Pierre Bleau, Pierre Blier, et al.
The International Journal of Neuropsychopharmacology|July 11, 2019
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)Maggie Fedgchin, Madhukar Trivedi, Ella J Daly, et al.
Psychological Medicine|August 25, 2022
Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 reportMehri Sajjadian, Rudolf Uher, Keith Ho, et al.
Arthritis Care & Research|November 10, 2012
Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritisYukiko Kimura, Jennifer E Weiss, Kathryn L Haroldson, et al.
The Canadian Journal of Cardiology|April 5, 2011
Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paperMichael H Gollob, Louis Blier, Ramon Brugada, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological TreatmentsSidney H Kennedy, Raymond W Lam, Roger S McIntyre, et al.
Journal of Affective Disorders|January 24, 2020
Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkersStephen Daniels, Thomas Horman, Thomas Lapointe, et al.
Pageof 51